Orange Book product · Brand (NDA)
QMIIZ ODT
MELOXICAM
At a glance
Oct 19, 2018
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 19, 2018
7 yr 9 mo ago
Today
Patent 8545879 expires
Listed drug product patent expiration.
Aug 31, 2030
in 4 yr 3 mo
Pharmaceutical detail
Active ingredient
MELOXICAM
Strength
7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
TE code
Not listed
Application
NDA 211210
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2025XIFYRMBrand (NDA)
NDA 218395 · AZURITY
- 2025QAMZOVABrand (NDA)
NDA 217593 · NANJING DELOVA
- 2020ANJESOBrand (NDA)
NDA 210583 · BAUDAX
- 2015VIVLODEXBrand (NDA)
NDA 207233 · ICEUTICA OPERATIONS
- 2004MELOXICAMBrand (NDA)
NDA 021530 · AVONDALE PHARMS
- 2000MOBICBrand (NDA)
NDA 020938 · BOEHRINGER INGELHEIM
- 2023MELOXICAMGeneric (ANDA)
ANDA 217579 · ASCENT PHARMS INC
- 2021MELOXICAMGeneric (ANDA)
ANDA 211398 · NOVITIUM PHARMA
- 2020MELOXICAMGeneric (ANDA)
ANDA 209487 · LUPIN
- 2009MELOXICAMGeneric (ANDA)
ANDA 077928 · NOVITIUM PHARMA
- 2006MELOXICAMGeneric (ANDA)
ANDA 077927 · UNICHEM
- 2006MELOXICAMGeneric (ANDA)
ANDA 078039 · CR DOUBLE CRANE
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8545879 | Aug 31, 2030 | in 4 yr 3 mo | Product |
